Literature DB >> 27644152

Metabolic pathways in the periphery and brain: Contribution to mental disorders?

Andrzej Nagalski1, Kamil Kozinski1, Marta B Wisniewska2.   

Abstract

The association between mental disorders and diabetes has a long history. Recent large-scale, well-controlled epidemiological studies confirmed a link between diabetes and psychiatric illnesses. The scope of this review is to summarize our current understanding of this relationship from a molecular perspective. We first discuss the potential contribution of diabetes-associated metabolic impairments to the etiology of mental conditions. Then, we focus on possible shared molecular risk factors and mechanisms. Simple comorbidity, shared susceptibility loci, and common pathophysiological processes in diabetes and mental illnesses have changed our traditional way of thinking about mental illness. We conclude that schizophrenia and affective disorders are not limited to an imbalance in dopaminergic and serotoninergic neurotransmission in the brain. They are also systemic disorders that can be considered, to some extent, as metabolic disorders.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Diabetes; Genetic risk factors; Insulin; Metabolism; Serious mental disorders

Mesh:

Substances:

Year:  2016        PMID: 27644152     DOI: 10.1016/j.biocel.2016.09.012

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

Review 2.  Mechanisms Underlying the Comorbidity of Schizophrenia and Type 2 Diabetes Mellitus.

Authors:  Yutaka Mizuki; Shinji Sakamoto; Yuko Okahisa; Yuji Yada; Nozomu Hashimoto; Manabu Takaki; Norihito Yamada
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

3.  Somatosensory amplification, health anxiety, and alexithymia in generalized anxiety disorder.

Authors:  Vijaya Kumar; Ajit Avasthi; Sandeep Grover
Journal:  Ind Psychiatry J       Date:  2018 Jan-Jun

Review 4.  Wnt/β-catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind.

Authors:  Joanna Bem; Nikola Brożko; Chaitali Chakraborty; Marcin A Lipiec; Kamil Koziński; Andrzej Nagalski; Łukasz M Szewczyk; Marta B Wiśniewska
Journal:  FEBS Lett       Date:  2019-06-30       Impact factor: 4.124

5.  Gut-Brain Axis Cross-Talk and Limbic Disorders as Biological Basis of Secondary TMAU.

Authors:  Luigi Donato; Simona Alibrandi; Concetta Scimone; Andrea Castagnetti; Giacomo Rao; Antonina Sidoti; Rosalia D'Angelo
Journal:  J Pers Med       Date:  2021-01-31

Review 6.  Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic Dysfunction.

Authors:  Kah Kheng Goh; Cynthia Yi-An Chen; Tzu-Hua Wu; Chun-Hsin Chen; Mong-Liang Lu
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

7.  Biomarkers for cognitive decline in patients with diabetes mellitus: evidence from clinical studies.

Authors:  Xue Zhao; Qing Han; You Lv; Lin Sun; Xiaokun Gang; Guixia Wang
Journal:  Oncotarget       Date:  2017-12-14

Review 8.  Altered brain metabolites in patients with diabetes mellitus and related complications - evidence from 1H MRS study.

Authors:  Xue Zhao; Qing Han; Xiaokun Gang; Guixia Wang
Journal:  Biosci Rep       Date:  2018-09-07       Impact factor: 3.840

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.